Valeriya Posternak

Valeriya Posternak's work experience includes:

- Lead Research Scientist at Spark Therapeutics, Inc. since February 2023 (ongoing)

- Senior Research Scientist at Spark Therapeutics, Inc. from June 2020 to February 2023

- Senior Scientist at Sanofi from April 2019 to June 2020, where they designed and optimized antibodies and mRNA therapeutics for cancer treatment

- Postdoctoral Fellow at Sanofi from October 2016 to April 2019

- PhD Candidate - Graduate Student at Geisel School of Medicine at Dartmouth College from August 2011 to October 2016, where they studied the effect of the MYC oncogene on mRNA cap methylation in cancer

- Undergraduate Research Assistant at Rutgers University from June 2010 to June 2011.

Valeriya Posternak obtained their Doctor of Philosophy (Ph.D.) degree in Cancer Biology, Genetics, and Biochemistry from the Geisel School of Medicine at Dartmouth between 2011 and 2016. Prior to that, they earned a Bachelor of Science (B.S.) degree in Microbial Biotechnology and Biochemistry from Rutgers University, which they attended from 2007 to 2011. There is no available information about their education before attending Rutgers University.